Gratus Capital LLC Qiagen N.V. Transaction History

Gratus Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$32.65 - $37.95 $302,698 - $351,834	-9,271 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$35.99 - $39.39 $14,216 - $15,559	-395 Reduced 4.09%	9,271 $351,000
Q2 2018 Aug 13, 2018	SELL	$31.23 - $37.47 $28,231 - $33,872	-904 Reduced 8.55%	9,666 $350,000
Q1 2018 May 10, 2018	SELL	$31.01 - $34.72 $7,163 - $8,020	-231 Reduced 2.14%	10,570 $342,000
Q3 2017 Nov 09, 2017	SELL	$31.02 - $32.94 $13,431 - $14,263	-433 Reduced 3.85%	10,801 $340,000
Q2 2017 Aug 08, 2017	BUY	N/A	11,234	11,234 $377,000

6.37M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.5B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Gratus Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Gratus Capital LLC with notifications on news.